Table 2.
The relationship between GLP-1 RAs, thyroid volume, and TSH in individuals with T2DM without any pre-existing thyroid pathology. Results obtained from the study by Sencar [39] and Köseoğlu [40].
| TSH before Exenatide (mU/L) |
TSH 6 Months after Exenatide (mU/L) |
p | Thyroid Volume before Exenatide (cm3) |
Thyroid Volume 6 Months after Exenatide (cm3) |
p | |
|---|---|---|---|---|---|---|
| Sencar 2019 [39] | 2.3 | 1.8 | 0.007 | 11.6 ± 9.0 | 12.1 ± 8.8 | 0.19 |
| Köseoğlu 2020 [40] | 2.36 ± 1.17 | 1.95 ± 0.91 | 0.007 | 17.39 ± 15.72 | 15.72 ± 13.17 | 0.043 |
Green indicates concordant results, while red indicates contrasting results. TSH: thyroid-stimulating hormone.